Advertisement
Home Blog Page 2017
Intrauterine device use among reproductive women is associated with a decreased incidence of ovarian cancer

Intrauterine Device Use May Reduce Incidence of Ovarian Cancer

0
Novel noncontraceptive benefit seen for all intrauterine devices
Supplementation with n-3 long-chain polyunsaturated fatty acids during pregnancy does not result in a lower incidence of early preterm delivery

n-3 PUFAs Do Not Lower Risk for Early Preterm Delivery

0
Maternal supplementation with n-3 long-chain polyunsaturated fatty acids did not lower risk
HIV infection is independently associated with an increased risk for atrial fibrillation

HIV Infection May Raise Risk for Atrial Fibrillation

0
Risk similar to known factors such as hypertension and diabetes
The incidence of mild cognitive impairment is increased in World Trade Center responders

Mild Cognitive Impairment Incidence Higher for WTC Responders

0
Incidence increased with PTSD severity; prolonged exposure a risk factor for apolipoprotein-ε4 carriers
Patients with hidradenitis suppurativa have an increased risk for long-term opioid use

Risk for Long-Term Opioid Use Up in Hidradenitis Suppurativa

0
Odds higher for HS patients with advancing age, ever smoking, history of depression, comorbidity
Certain mental health conditions are associated with an increased risk for unnecessary bilateral oophorectomy for nonmalignant indications

Psychiatric Disorders May Up Risk for Bilateral Oophorectomy

0
Mental health conditions may play a role in physical symptoms, gynecologic complaints
OxyContin maker Purdue Pharma has reached a tentative settlement with a coalition of states and local governments that sued the company over its role in America's ongoing opioid crisis

Purdue Pharma Tentatively Reaches Settlement in Opioid Lawsuits

0
Deal is said to be worth $10 billion to $12 billion; company will not admit to wrongdoing
As concern grows over hundreds of lung illnesses tied to vaping

President Pushing for Nationwide Ban on Flavored E-Cigarettes

0
Details of plan to phase out flavored e-cigarettes from the market expected during the next few weeks
The eventual elimination of chemical testing on mammals was announced Tuesday by the U.S. Environmental Protection Agency.

EPA to Phase Out Chemical Testing on Mammals

0
Agency plans 30 percent reduction in number of studies that require use of mammals by 2025
A new strain of Streptococcus pyogenes is causing scarlet fever

New Strain of S. pyogenes Causing Scarlet Fever in U.K.

0
New, more toxigenic strain may explain recent increase in scarlet fever activity in England